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Dilong, also known as earthworm, has been widely used in traditional Chinese medicine (TCM) for thousands of years. Schwann
cell migration and proliferation are critical for the regeneration of injured nerves and Schwann cells provide an essentially
supportive role for neuron regeneration. However, the molecular mechanisms of migration and proliferation induced by dilongs
in Schwann cells remain unclear. Here, we discuss the molecular mechanisms that includes (i) migration signaling, MAPKs
(mitogen-activated protein kinases), mediated PAs and MMP2/9 pathway; (ii) survival and proliferative signaling, IGF-I (insulin-
like growth factor-I)-mediated PI3K/Akt pathways and (iii) cell cycle regulation. Dilong stimulate RSC96 cell proliferation and
migration. It can induce phosphorylation of ERK1/2 and p38, but not JNK, and activate the downstream signaling expression of
PAs(plasminogenactivators)andMMPs(matrixmetalloproteinases)inatime-dependent manner.In addition, Dilongstimulated
ERK1/2 and p38 phosphorylation was attenuated by pretreatment with chemical inhibitors (U0126 and SB203580), and small
interfering ERK1/2 and p38 RNA, resulting in migration and uPA-related signal pathway inhibition. Dilong also induces the
phosphorylation of IGF-I-mediated PI3K/Akt pathway, activates protein expression of PCNA (proliferating cell nuclear antigen)
and cell cycle regulatory proteins (cyclin D1, cyclin E and cyclin A) in a time-dependent manner. In addition, it accelerates G1-
phaseprogressionwithearlierS-phaseentry andsigniﬁcantnumbersofcellsentered theS-phase.ThesiRNA-mediatedknockdown
of PI3K that signiﬁcantly reduces PI3K protein expression levels, resulting in Bcl2 survival factor reduction, revealing a marked
blockage of G1 to S transition in proliferating cells. These results reveal the unknown RSC96 cell migration and proliferation
mechanism induced by dilong, which ﬁnd use as a new medicine for nerve regeneration.
1.Introduction
1.1. Regeneration of Nerves. Nerve regeneration is a complex
phenomenon that has interested scientists for many years.
Neurons can be separated into central and peripheral
nervous systems (PNSs), which have diﬀerent anatomical
structures and regenerative ability. In mammals, the central
neurons without a myelin sheath are diﬃcult to regenerate.
In contrast to the central nervous system, the PNS with a
myelin sheath exhibit easier regrowth [1]. Regrowth ability
results from intrinsic neuronal activities and surrounding
non-neuronal properties in which Schwann cells provide2 Evidence-Based Complementary and Alternative Medicine
an essentially supportive activity for neuron regeneration.
Schwann cells are the supporting cells of the PNS and
can diﬀerentiate into the myelin sheath of the PNS and
proliferate and migrate into the distal end of the injured
nervearea [2].Moreover,Schwann cellmigration,which also
occurs at the proximal end of the injured area, provides a
guide for regenerating axons by interacting with nerve ﬁbers
or basal lamina [3]. Since Schwann cell migration is critical
for axonal elongation and remyelination of injured nerves
[3, 4], those factors that regulate Schwann cell migration
have been widely investigated. Peripheral nerve injury locally
activates Schwann cells and macrophages to synthesize
a cocktail of neurotrophic factors, adhesion molecules,
cytokines and growth-promoting surface molecules [5, 6].
However, the mechanisms of action of these regulating
factors on Schwann cell migration, proliferation and signal
transformation remain unclear.
1.2. Pathways that Play a Role in Cellular Proliferation and
Migration. The mitogen-activated protein kinase (MAPK)
family plays an essential role in inducing cell proliferation
[7]a n dm i g r a t i o n[ 8]. Extracellular signal-regulated protein
kinase (ERK) that belongs to MAPK family has been studied
extensively[9].ResultsrevealthatERKisrelatedtomigration
of various cell types, including ﬁbroblasts and carcinoma
cells [10, 11], but not in Schwann cells. Recently, several
studies found that after nerve injury, the increased activation
of ERK [12] phosphorylation promotes neurite outgrowth
[13]. Interestingly, to promote migration, growth cones at
the tip of an axon secrete proteases that are thought to
dissolve cell-cell and cell-matrix adhesions during peripheral
nerveregeneration. These proteases includetheplasminogen
activators(PAs), tissue PA (tPA)and urokinase PA (uPA)and
their substrate, plasminogen [14]. Many experiments have
determined that after injury, a rapid increase of tissue PA
expression has been observed in neurons [14, 15]. Tissue
PA or uro kinase PA activates plasmin that consequently
activates MMP-9 and MMP-2 [16]. It has been shown
that the lack of plasminogen activators aﬀects MMP-9
and MMP-2 activity [17]. However, little is known about
Schwann cell migration using MEK/ERK signaling pathways
to active PAs and MMPs. In addition, accumulating evidence
has also indicated that c-Jun NH2-terminal kinase (JNK)
and p38, the other two members of the MAPK super
family, have the aﬀection on cell migration regulation [10].
To promote migration in cells, the expression of matrix-
degrading proteolytic enzymes (PAs and MMPs) could be
regulated by JNK [18]a n dp 3 8[ 19] signal transduction
pathways.
2.RoleofGrowthFactors
2.1. Insulin-Like Growth Factors. Insulin-like growth factor-I
(IGF-I) is a polypeptide hormone synthesized by proliferat-
ing Schwann cells [20]. The secretion of IGF-I is controlled
by the growth hormone [21]. In response, IGF-I stimulates
the growth and diﬀerentiation of fetal neurons [22]a n d
increases neurite sprouting and outgrowth in vitro [23, 24].
Interestingly, IGF-I not only stimulates proliferation but
also promotes survival in several cell types. It can rescue
Schwann cells from apoptosis via PI3-K signaling, which is
upstream from caspase activation [25]. In vivo,t h es i g n a l
cascade for early upregulation of IGF-I has been shown to
promote retinal ganglion cells (RGCs) survival and axonal
regeneration through the PI3K/Akt system after optic nerve
injury in goldﬁsh [26].
2.2. PI3K/Akt System and Peripheral Nerve Regulation.
Many studies have investigated the eﬀects of the PI3K/Akt
system on peripheral nerve regeneration. IGF-I functions
as a progression factor in the cell cycle [27], promoting
G1/S cell cycle progression via the phosphatidylinositol 3-
kinase/serine-threonine kinase( P I 3 K / A k t )p a t h w a y ,r e s u l t -
ing in DNA synthesis and cell proliferation [28]. This hor-
mone protectsneuronsinthePNSfromapoptosisbyactivat-
ing the PI3K/Aktpathway, which in turn phosphoralates Bad
and activates Bcl2, an anti-apoptotic protein that interferes
with the activation of caspases [26, 29, 30]. Furthermore,
it has been suggested that the inhibition of PI3K activation
can completely blockSchwann cell proliferation and survival
[31]. Generally, these data strongly indicate that IGF-I is
an important molecule for controlling regeneration after
nerve injury. Therefore, IGF-I has been used as a therapeutic
target forthetreatment ofperipheralnerve injury and motor
neuron diseases [32]. Insulin-like growth factor I (IGF-I)
is currently in clinical trials for treatment of amyotrophic
lateral sclerosis (ALS) based on its neuroprotective eﬀect on
motor neurons [33].
3.TraditionalChinese Medicine
3.1. Is There a Role for Dilong? The pharmacology and clini-
cal application of traditional Chinese medicine has been well
documentedforseveralthousand years. Recently,biomedical
material science combined with Chinese herbal medicine
has been applied to analyses of nerve regeneration. Several
Chinese medicines have been identiﬁed as enhancing neuron
regeneration. In Tsai’s study, ginsenoside Rb1 (GRb1) ﬁlled
into a silicon rubber chamber can bridge a 15-mm gap
in injured rat sciatic nerves [34]. Therefore, the herbal
medicine has a good potential for treating injured nerves.
The earthworms, also called“dilong”in Chinese,are a widely
used Chinese herbal medicine [35]. Extracting medicinal
compounds from dilong has traditionally been practiced by
indigenous people throughout the world, more particularly
in Asia [36]. The potential treatment eﬀects of earthworms
may come from their dense soil-based nutritional content
[37].
BuYang Huan Wu Tang (BYHWT), a Chinese herb com-
plex prescription, has been applied for treating the sequelae
of stroke, eye and mouth distortion, stiﬀness in the tongue
and aphasia, as well as atrophy and paralysis of lower limbs.
BYHWT consists of Dilong (Earthworm), Chi Shao (Peony
Red), Tao Ren (Persica), Hong Hua (Carthamus), Dang Gui
(Chinese Angelica Root), Huang Qi (Astragalus) and Chuan
Xiong (Cnidium). It has been shown that BYHWT can
increasethelevelofNOincerebralinfarctratsandreducethe
area of cerebral infarct [38]. Furthermore, several researchEvidence-Based Complementary and Alternative Medicine 3
Earthworm extracts
IGF-I
pIGE-IR
pAkt
pBad
Cell cycle activation
(cyclin D1, E and A)
BcI2 MMP2 MMP9
Migration Survival & proliferation
Nerve regeneration
Plasmin Plasminogen
uPA/tPA
p-p38 pERK
RSC96 schwann cell
PI3K
Figure 1: Schematic model of migrative survival and proliferative eﬀects of Dilong extract on Schwann cell.
results indicate that BYHWT may promote the repair and
regeneration of neurons and injured nerve ﬁbers [39, 40].
After administered BYHWT for 4 weeks, the conduction
velocity of pulses in the newly regenerative nerve of the
treatment group was signiﬁcantly faster than that of the
control group. The blood vessel area around the regenerative
nerves in the treatment group was also considerably larger.
These results provide many information for further studies
on the role of Dilong in nerve regeneration.
3.2. Evidence for Diverse Role of Dilong. Previous studies of
dilong have shown its antimicrobial [41], hepatoprotective
[42], anticancer and scar wound-healing characteristics [35].
The anti-inﬂammatory activity together with anti-oxidant
properties may be due to the high polyphenolic content
in dilong tissue [42]. Moreover, crude dilong extract has a
thrombolytic eﬀect that could signiﬁcantly promote blood
circulation and remove stasis [43]. In healthy human vol-
unteers, orally administered dilong powder increased levels
of tissue plasminogen activator and ﬁbrinolytic activity [44].
These results suggest that earthworm powder represents a
possible oral thrombolytic agent.
3.3. Hypothetical Role of Dilong in Nerve Regulation. In
vivo experiments have also found that a mixed prescription
of liquid extracted from dilong more obviously improves
peripheral nerve regeneration than icariin [45]. Therefore,
many scientists focus on purifying the contents of crude
dilong powder. Diﬀerent contents of dilong extract will be
discussed as follows. First, Lumbrokinase extracted from
dilong has been used to treat stroke and cardiovascular dis-
eases [41]. Lumbrokinase is a group of proteolytic enzymes
[36]. It includes a plasminogen activator and plasmin [46]
that serve toactivate plasminogen and dissolve ﬁbrin directly
[47]. Second, dilong tissue homogenates have revealed
a glycolipoprotein mixture composed of macromolecules
referredtoasG-90.G-90possesses severalgrowthfactorsand
also participates in tissue regeneration and wound healing
[48]. Further experimental works are needed to more fully
characterize the molecules and potential mechanisms of
dilong extract involved in peripheral nerve regeneration.
There is still no conclusive explanation for the possible
molecular mechanism involved in Schwann cell migrat-
ing and proliferating events. Peripheral nerve regeneration
requires a permissive environment and activation of the
intrinsic growth capacity of neurons. Axon regrowth and
remyelination of the regenerated axons by Schwann cells
are both essential. Multiple factors including neurotrophic
factors, extracellular matrix (ECM) proteins and hormones
participate in Schwann cell dediﬀerentiation, proliferation
andremyelination.Aschematicmodel(Figure 1)ispr oposed
to explain the migrative, survival and proliferative eﬀects of
dilong extract on Schwann cells. In this review article, we
will discuss the peripheral nerve regeneration mechanisms,
with particular attention to the proliferation and migration
of Schwann cells induced by dilong.
4.MigrationSignaling:MAPKsMediated
PAs and MMP2/9 Pathway
4.1. MAPK and Schwann Cell Migration. The MAPK family
isacrucialregulatorofpathwaysinvolvedincellproliferation
[7]a n dm i g r a t i o n[ 8]. JNK, p38 and ERK1/2, the members
of MAPKs family, play crucial roles in nerve cells migration
[10]. The whole MAPKs pathway is illustrated by the
dotted line in Figure 1. This study further demonstrated that
dilong extract stimulated ERK1/2 and p38, but not JNK
activation in a time-dependent manner, leading to Schwann4 Evidence-Based Complementary and Alternative Medicine
cell migration. Dilong-induced Schwann cell motility and
phosphorylation of ERK1/2 and p38 were both attenuated
by pretreatment with MEK1/2 (U0126) and p38 (SB203580)
inhibitors. Transfection with siRNA of MEK1/2 and p38
signiﬁcantly reduced migration in response to dilong extract
in Schwann cells as well. The signaling migration pathway
in earthworm-stimulated Schwann cells, inducing the acti-
vation of uPA and tPA mediated through the ERK1/2 and
p38. To promote migration, cells secrete proteases (PA and
uPA) that are thought to degrade matrix molecules and cell
adhesion. The ERK1/2 and p38 phosphorylation leads to the
expression of uPA and tPA that occurs in a time-dependent
manner, during the elevation of MMP9 and MMP2 levels
and activity. In addition, the highly expressed uPA in
the epidermis of damaged tissue is also regulated by the
ﬁbroblast growth factor (FGF-2) that aﬀects MAPK kinase
(MEKK-1) and MEKK-1s downstream extracellular signal-
regulated kinases (ERK1/2) for controlling uPA expression
[49]. Another regulating factor is p38. In endothelial cell
migration, the p38 MAPK pathway also participates in by
regulating uPA expression [50].
4.2. Dilong Extract and Signaling. In Chang’s study, results
reveal that dilong extract enhances uPA expression directly
through the ERK1/2 and p38 signaling pathway [51]. To
promotemigration, cellssecreteproteasesthatarethoughtto
degrade matrix molecules and cell adhesion. These proteases
include tPA and uPA [14]. In contrast to PAs, PAI-1 is
thought to be the main inhibitor of the plasminogen activa-
tors. Chang’s study clearly shows that the phosphorylation
of ERK1/2 and p38 accompanies the increased expression
of uPA, but PAI-1 expression is gradually decreased. Inter-
estingly, tPA levels reached the maximal early at 2h, and
then began to decline slightly until 20h. It suggests that
the maximum expression of tPA occurred early following
4h treatment, because tPA is the main PAs in the nerve to
facilitate growth cone movement by digesting extracellular
matrices and cell adhesions. Pittman and DiBenedetto [52]
reported that the overexpressing tPA can regenerate neurites
to a greater extent and migrate faster than the control group
incomplexextracellular matrix. Ulfhammeretal. [53]f oun d
thattPAactivationcouldbe mediatedthroughp38pathways,
leadingtoanincreaseintPAexpression.Chang’sexperiments
further show that SB203580 inhibited p38 phosphorylation
and suppressed tPA protein expression in Schwann cells.
Thus, tPA activation occurs not only through ERK1/2
activation but also through the p38 signaling pathway.
5.Proliferativeand Survival Signaling:
IGF-I-Mediated PI3K/AktPathways
The PI3K/Akt signaling mediated by IGF-I (dot-dashed
line in Figure 1) plays an important role in cell prolifer-
a t i o na sw e l la sc e l ls u r v i v a l[ 14, 28, 30, 54]. IGF-I is a
polypeptide hormone synthesized by proliferating Schwann
cells [20] and it directly induces neurite outgrowth via a
PI3K/Akt-dependent mechanism [26, 55]. Moreover, IGF-
I rescues Schwann cells from apoptosis via PI3K signaling
that is upstream from caspase activation [56], and also
requires that PI3K/Akt-mediated progression from G1 to
S phase of the cell cycle [54]. Conversely, PI3K inhibitors
blocked the anti-apoptotic and protective eﬀects of IGF-
I, demonstrating that PI3K is essential for trophic factor-
induced survival of Schwann cells [30, 56]. The plasma
membrane is subsequently phosphorylated by PI3K. This
activates the protein kinase Akt and the following steps of
cell proliferation. IGF-1 seems to play an important role in
controlling brain growth and cell number [57, 58]. IGF-
1 injection in embryos increased rat cerebral cortex DNA
content by 28%, suggesting a role for IGF-1 in control of
brain growth. IGF-1 therefore seems to be a mitogen for
cortical precursors during embryonic development [28].
6.Cell-CycleRegulation
6.1. IGF-1. IGF-I has also been shown to function as a
progression factor in the cell cycle by regulating expression
levels [59]. It can promote G1/S cell cycle progression via
the phosphatidylinositol 3-kinase/serine-threonine kinase
(PI3K/Akt) pathway, which then results in DNA synthe-
sis and cell proliferation. Chang’s analysis indicates that
treatment with dilong extract induces phosphorylation of
the IGF-I-mediated phosphatidylinositol 3-kinase/serine-
threonine kinase (PI3K/Akt) pathway, it activates protein
expression of cell nuclear antigen (PCNA) in a time depen-
dent manner [60]. Cell cycle progression is tightly regulated
byacomplexnetworkofcellcycleregulatory molecules,such
as cyclins. Proliferating cells pass through several cell cycle
checkpoints, such as the G1 to S transitions. G1 checkpointis
consideredtobethemost important one inthereplication of
DNA and mitosis. The results show that G1 transits into the
S phase in 12–16h, and S transits into the G2 phase 20h after
exposure to dilong extract. Strong expression of cyclin D1,
cyclin E and cyclin A occurs in a time-dependent manner.
Progression through the ﬁrst gap phase (G1) requires cyclin
D and cyclin E activity [61]. Expression of these two cyclin
proteins orchestrates the progression of cells through G1 and
into the S-phase ofthecell cycle[62,63].CyclinA isrequired
for DNA replication in the S-phase and in mitosis initiation
(M-phase) [63].
6.2. Small Interfering RNA. Small interfering RNA (siRNA)-
mediated knockdown of PI3K signiﬁcantly reduced P13K
protein expression levels, resulting in Bcl2 reduction of
survival factor and a marked blockage of G1 to S transition
in proliferating cells. These results demonstrate that dilong
extract promotes the proliferation and survival of RSC96
cells via IGF-I signaling. The mechanism is primarily depen-
dent on the PI3K protein [51]. Dilong extract promoted
DNA replication and growth of RSC96 cells by upregulating
the sequential expression of cyclin D1, cyclin E and cyclin
A, thereby elevating the number of cells in the S phase in a
time-dependent manner. Studies on the proliferative action
of IGF-I in cultured ﬁbroblasts (BALB/c-3T3) [64, 65]a n d
mammary epithelial cells [66] indicate that IGF-I acts to
stimulate progression through G1 or the G0/G1 transition.
Chang’s data are in agreement with the results of those
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by cyclins but also mediated by IGF-I [51]. Therefore, cell
cyclealterationsmaybecriticaldeterminantsoftheincreased
proliferation potency-induced dilong extract.
7.PerspectivesonSchwannCell Migration
The mechanism in which dilong extract regulates Schwann
cell migration, proliferation and survival is investigated in
this article. Speciﬁc signaling pathways in dilong-stimulated
Schwann cells are shown in Figure 1. For thousands of years
dilong has been used as a drug for various diseases in China
and the Far East [44]. Until now, the function of dilong
extract on nerve regeneration is still unclear. The devel-
opment and regeneration of the PNS is highly dependent
on the migration of Schwann cells and the extension of
axons toward their distant targets. Recently studies revealed
that MAPKs, including JNK, p38 and ERK1/2, play crucial
roles in nerve cell migration [10]. Dilong-induced Schwann
cell motility and phosphorylation of ERK1/2 and p38 were
both attenuated by pretreatment with MEK1/2 (U0126) and
p38 (SB203580) inhibitors. In addition, transfection with
siRNA of MEK1/2 and p38 signiﬁcantly reduces migration
in response to dilong extract in Schwann cells. Using
inhibitors and siRNA, the migrative eﬀects of dilong extract
on Schwann cells were further identiﬁed to be ERK1/2
and p38 signaling dependent. These assays help researchers
to examine the individual steps in the complex signaling
cascades and clearly illustrate eﬀects of direct dilong extract
on Schwann cell migration. Dilong extract enhances uPA
expression directly through the ERK1/2 and p38 signaling
pathway. When cells treated with dilong extract resulted in
ERK1/2and p38 phosphorylation, the expression ofuPA and
tPA lead to elevated MMP9 and MMP2 levels and activity.
Several experiments have indicated that dilong ﬁbrinolytic
enzyme acts as a plasminogen activator [67], suggesting
a tPA-like function [68]. Another family of proteases, the
matrix metalloproteases (MMPs), are also implicated in
peripheral nerve regeneration [69], and involved in many
cell migration phenomena and produced by many cell types,
including neurons [70]. MMPs are secreted as inactive
molecules and require activation via other proteases [71].
Plasmin, activated by tPA or uPA, can activate MMP-9 and
MMP-2 [16]. A novel ﬁbrinolytic enzyme isolated from the
earthworm Pheretima aspergillum can directly and strongly
dissolve human thrombi and ﬁbrin, and also activate human
plasminogen to plasmin.
8.Roleofthe GlycolipoproteinG-90
G-90, a biologically active glycolipoproteincomplex, isolated
from whole dilong tissue extract (Eisenia foetida)[ 61].
There are several function attributed to G-90, including an
insulin-like growth factor (IGF like), an immunoglobulin-
like growth factor (IgFG-like) and epidermal growth factor
(EGF) [48] and mitogenicity [72]. G-90 also has an apparent
protective eﬀect against the toxicity of H2O2 and stimulated
the growth of the cell [73] and show anticoagulative and
ﬁbrinolytic activities [74, 75]. The results revealed that
G-90 also participates in tissue regeneration and wound
healing. The glycolipoprotein tissue homogenate extract
from the earthworms Eisenia foetida (G-90) can activate
signal transduction pathways, leading to wound healing. G-
90 promote and cause an increased concentration of EGF
and FGF as observed 6h after wounding on mouse skin
[76].
Stimulation of cell proliferation during nerve regen-
eration usually involves initiation and progressive activ-
ity of growth factors. As mentioned previously, these
growth factors (GDNF, BDNF, FGF and NGF) can acti-
vate MAPK pathway to stimulate Schwann cell migration.
Highly expressed uPA in the epidermis of damaged tissue
is regulated by the FGF-2 that activates MAPK kinase
(MEKK-1) and its downstream ERK1/2 [49]. Despite these
encouraging results, the possible beneﬁcial eﬀect of G-90
extracted from earthworm on peripheral nerve regeneration
still remains unclear and requires further investigation and
conﬁrmation.
9.NeuralCell AdhesionMolecule
The neural cell adhesion molecule (NCAM) is a member
of the immunoglobulin superfamily. Several studies showed
that NCAM-induced neurite outgrowth depends on Ras-
MAPK pathway activation [77]. NCAM-dependent cell
m i g r a t i o nt oﬁ b r o n e c t i nr e q u i r e da ni n t a c tM E K - E R Ks i g -
naling pathway [78]. The putative adhesins of the immuno-
globulin superfamily presumably from dilong extract could
promote migration by MEK-ERK pathway activation. These
bioactive compounds may indirectly cause ERK activation
or directly activate plasminogen to plasmin by ﬁbrinolytic
enzyme, resulting in Schwann cell migration promotion
during nerve regeneration.
10.ActionofDilong Extract
We suggest that dilong extract promotes proliferation by
allowing Schwann cell survival. The IGF-IGFIR-Akt-Bcl2
axis stimulates tissue growth [21] and axonal regeneration
[26]. IGF in certain cells, such as hematopoietic cells,
functions as an inhibitor of cell death [79]. Activation of
the PI3K/Akt pathway promotes cell survival. Activation of
Akt leads to the phosphorylation of Bad [80] and connects
a proximal survival signal with the Bcl-2 family to protect
against apoptosis. Results of the immunoblotting assay
showed that PI3K siRNA blocked the earthworm extract-
induced expression of the anti-apoptotic proteins pBad and
Bcl2.Cellcycleproﬁleswere obtainedforearthwormextract-
treated Schwann cells after transfection with PI3K siRNA
and for treated cells that were not transfected with PI3K
siRNA. Knockdown of PI3K led to a signiﬁcant inhibition
of DNA synthesis in cells treated with earthworm extract
for 24h as evidenced by the fact that the number of
S phase proliferating cells decreased. These data indicate
that Schwann cell survival and proliferation are PI3K-
dependent processes that are mediated, atleast in part, by
IGF-I.6 Evidence-Based Complementary and Alternative Medicine
11.TheFutureofNerveCellRegenerationand
Possible Inﬂuenceof Dilong
The ﬁndings mentioned previously provide researchers an-
other novel function during neuron regeneration. Although
the treatment beneﬁts of earthworms have been strongly
supported, more precise studies are still required to: (i)
reveal the precise and complete biochemical proﬁle and
(ii) suggest accurate doses of medication. In Boyd’s study,
the results suggested a dose-dependent facilitation and
inhibition of peripheral nerve regeneration by brain-derived
neurotrophic factor (BDNF). In contrast to the low-dose
group, the high doses of BDNF (12–20μgday −1 for 28
days) signiﬁcantly inhibited motor axonal regeneration [81].
Chang’s study suggested similar results [51]. As a word of
caution, an excessive earthworm extract load in the medium
could provoke an adverse response to recovery of neuron
regeneration. In other words, there are threshold dosages
above and below a certain eﬀective dose. The ﬁndings of
our study provide another novel function during neuron
regeneration. However, the nerve growth-suppressing action
by high doses of earthworm extract at concentrations of
250–1000mgmL−1, indicates that an excessive earthworm
extract load in the medium could provoke an adverse
response to neuron regeneration recovery. It demonstrates
that excessive supplement could saturate the neurotrophin
receptor, P75, to block the neuron regrowth-promoting
function. Therefore, an appropriate dose of earthworm
extract should be carefully selected to reach the highest
potential for enhanced Schwann cell migration.
Based on these ﬁndings, we believe that certain com-
ponents of earthworm extract can exert cell migration,
proliferation and survival activity. The results demonstrate
that dilong extract canstimulate Schwann cell migration and
upregulate PAs and MMP2/9 expression mediated through
the MAPK pathways, ERK1/2 and p38. Earthworm extract
also stimulates Schwann cell proliferation and survival
throughthePI3K/AktsystemmediatedbyIGF-I.Theactivity
of dilong extract is probably related to its ability to induce
G1 phase cell cycle progression by altering the expression of
proteins that control the cell cycle (cyclin D1, cyclin E and
cyclin A), resulting in the upregulation of the anti-apoptotic
Bcl2 protein. Further analyses are essential to determine the
presence ofother bioactive compoundsin dilong extract that
might promote cell migration, survival and proliferation as
well as the optimal dose of dilong extract.
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